Department of Cardiovascular and Endovascular Surgery, Arizona Heart Institute, Arizona, USA.
Ann Thorac Surg. 2010 Jul;90(1):78-82. doi: 10.1016/j.athoracsur.2010.03.091.
The objective of our study is to determine the feasibility of thoracic aortic endografting in octogenarians.
Between 2000 and 2006 a total of 504 consecutive patients from two high-volume institutions underwent thoracic endoluminal graft repair for various thoracic aortic pathologies. The following devices were used: Gore TAG (W.L. Gore, Flagstaff, AZ); Talent (Medtronic, Minneapolis, MN); and Zenith (Cook, Inc, Bloomington, IN). One hundred one (101 of 504; 20%) patients were octogenarians; 60 males (1.5:1, M:F) with a mean age of 83.7 years. Indications for intervention included the following: atherosclerotic aneurysms, 75 (75 of 101, 74%); acute and chronic dissections, 11(11 of 101, 11%); penetrating aortic ulcers, 9 (9 of 101, 9%); contained ruptures, 5 (5 of 101, 5%); and 1 transection (1 of 101, 1%). Mean length of follow-up was 3.4 +/- 2.1 years.
No intraoperative deaths were noted. Thirty-day mortality was 10% (10 of 101 patients) with an overall late mortality of 26.7% (27 of 101 patients). Mean hospital stay was 6.3 days. A total of 12 neurologic events were noticed: 2 paraplegia (2 of 101, 2%); 4 paraparesis (4 of 101, 4%), 3 with full recovery; and 6 (6 of 101, 6%) cerebrovascular accidents with full recovery in half. A total of 15 endoleaks (15 of 101, 15%) were seen and, in 11, interventions were required.
Our data suggest that technical success is high and age-specific outcomes in this group of patients are favorable. Further studies are warranted.
本研究旨在确定在 80 岁以上人群中行胸主动脉腔内修复术的可行性。
在 2000 年至 2006 年期间,两个高容量中心的 504 例连续患者因各种胸主动脉病变接受了胸主动脉腔内移植物修复。使用了以下器械:戈尔 TAG(戈尔,弗拉格斯塔夫,亚利桑那州);Talent(美敦力,明尼阿波利斯,明尼苏达州);和 Zenith(库克公司,布鲁明顿,印第安纳州)。101 例(504 例中的 101 例,20%)患者为 80 岁以上人群;60 例男性(1.5:1,男:女),平均年龄 83.7 岁。干预的指征包括:动脉粥样硬化性动脉瘤,75 例(101 例中的 75 例,74%);急性和慢性夹层,11 例(101 例中的 11 例,11%);穿透性主动脉溃疡,9 例(101 例中的 9 例,9%);包含性破裂,5 例(101 例中的 5 例,5%);和 1 例横断(101 例中的 1 例,1%)。平均随访时间为 3.4 +/- 2.1 年。
术中无死亡病例。30 天死亡率为 10%(101 例患者中的 10 例),总晚期死亡率为 26.7%(101 例患者中的 27 例)。平均住院时间为 6.3 天。共发生 12 例神经事件:2 例截瘫(101 例中的 2 例,2%);4 例截瘫(101 例中的 4 例,4%),3 例完全恢复;和 6 例(101 例中的 6 例,6%)脑血管意外,半数完全恢复。共发现 15 例内漏(101 例中的 15 例,15%),其中 11 例需要介入治疗。
我们的数据表明,技术成功率高,该组患者的年龄特异性结果良好。需要进一步的研究。